KentWilliamMouwMD

Radiation Oncologist, Brigham & Women's Hospital/Dana-Farber Cancer Institute

Dr. Mouw is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2011 - 2015
Brigham and Women's HospitalInternship, Internal Medicine, 2010 - 2011
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2010

PubMed

361 citations
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Paz Polak, Jaegil Kim, Lior Z. Braunstein, Rosa Karlic, Nicholas J Haradhavala
Nature Genetics. 2017-08-21
98 citations
Analysis of somatic microsatellite indels identifies driver events in human tumors
Yosef E. Maruvka, Kent W. Mouw, Rosa Karlic, Prasanna Parasuraman, Atanas Kamburov
Nature Biotechnology. 2017-09-11
122 citations
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.
Nicholas J. Haradhvala, Jaegil Kim, Yosef E. Maruvka, Paz Polak, Daniel Rosebrock
Nature Communications. 2018-05-01

Journal Articles

Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic
Kent W Mouw, Paul L Nguyen, JAMA Oncology

Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 PandemicAugust 2020
Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 PandemicAugust 2020

Active Surveillance for Low-Risk Prostate Cancer in Black PatientsMay 22nd, 2019